P72 ORAL TREATMENT WITH PBI-4050, A NOVEL FIRST-IN-CLASS ANTI-FIBROTIC COMPOUND, REDUCES HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA

✍ Scribed by Gagnon, L.; Geerts, L.; Doucet, A.; Sarra-Bournet, F.; Tremblay, M.; Hince, K.; Abbott, S.; Duceppe, J.-S.; Zacharie, B.; Penney, C.; Laurin, P.; Grouix, B.

• Book ID: 122278012
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 60 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)60235-X